Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 16 entries
Sorted by: Best Match Show Resources per page
BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Bajaj S, Das AK, Kalra S, Sahay R, Saboo B, Das S, Shunmugavelu M, Jacob J, Priya G, Khandelwal D, Dutta D, Chawla M, Surana V, Tiwaskar M, Joshi A, Shrestha PK, Bhattarai J, Bhowmik B, Latt TS, Aye TT, Vijayakumar G, Baruah M, Jawad F, Unnikrishnan AG, Chowdhury S, Pathan MF, Somasundaram N, Sumanathilaka M, Raza A, Bahendeka SK, Coetzee A, Ruder S, Ramaiya K, Lamptey R, Bavuma C, Shaikh K, Uloko A, Chaudhary S, Abdela AA, Akanov Z, Rodrìguez-Saldaña J, Faradji R, Tiago A, Reja A, Czupryniak L.
PMID: 31102253
Diabetes Ther. 2019 Aug;10(4):1189-1204. doi: 10.1007/s13300-019-0629-z. Epub 2019 May 17.

The past three decades have seen a quadruple rise in the number of people affected by diabetes mellitus worldwide, with the disease being the ninth major cause of mortality. Type 2 diabetes mellitus (T2DM) often remains undiagnosed for several...

Cite
Bajaj S, Das AK, Kalra S, et al. BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion. Diabetes Ther. 2019;10(4):1189-1204doi: 10.1007/s13300-019-0629-z.
Bajaj, S., Das, A. K., Kalra, S., Sahay, R., Saboo, B., Das, S., Shunmugavelu, M., Jacob, J., Priya, G., Khandelwal, D., Dutta, D., Chawla, M., Surana, V., Tiwaskar, M., Joshi, A., Shrestha, P. K., Bhattarai, J., Bhowmik, B., Latt, T. S., Aye, T. T., Vijayakumar, G., Baruah, M., Jawad, F., Unnikrishnan, A. G., Chowdhury, S., Pathan, M. F., Somasundaram, N., Sumanathilaka, M., Raza, A., Bahendeka, S. K., Coetzee, A., Ruder, S., Ramaiya, K., Lamptey, R., Bavuma, C., Shaikh, K., Uloko, A., Chaudhary, S., Abdela, A. A., Akanov, Z., Rodrìguez-Saldaña, J., Faradji, R., Tiago, A., Reja, A., & Czupryniak, L. (2019). BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion. Diabetes therapy : research, treatment and education of diabetes and related disorders, 10(4), 1189-1204. https://doi.org/10.1007/s13300-019-0629-z
Bajaj, Sarita, et al. "BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 10,4 (2019): 1189-1204. doi: https://doi.org/10.1007/s13300-019-0629-z
Bajaj S, Das AK, Kalra S, Sahay R, Saboo B, Das S, Shunmugavelu M, Jacob J, Priya G, Khandelwal D, Dutta D, Chawla M, Surana V, Tiwaskar M, Joshi A, Shrestha PK, Bhattarai J, Bhowmik B, Latt TS, Aye TT, Vijayakumar G, Baruah M, Jawad F, Unnikrishnan AG, Chowdhury S, Pathan MF, Somasundaram N, Sumanathilaka M, Raza A, Bahendeka SK, Coetzee A, Ruder S, Ramaiya K, Lamptey R, Bavuma C, Shaikh K, Uloko A, Chaudhary S, Abdela AA, Akanov Z, Rodrìguez-Saldaña J, Faradji R, Tiago A, Reja A, Czupryniak L. BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion. Diabetes Ther. 2019 Aug;10(4):1189-1204. doi: 10.1007/s13300-019-0629-z. Epub 2019 May 17. PMID: 31102253; PMCID: PMC6612329.
Copy Download .nbib Format: NLM
The MDR1/ABCB1 gene rs 1045642 polymorphism in colorectal cancer.

Archives of medical science : AMS

Mrozikiewicz-Rakowska B, Malinowski M, Nehring P, Bartkowiak-Wieczorek J, Bogacz A, Żurawińska-Grzelka E, Krasnodębski P, Muszyński J, Grzela T, Przybyłkowski A, Czupryniak L.
PMID: 32051713
Arch Med Sci. 2019 Sep 26;16(1):112-117. doi: 10.5114/aoms.2017.70329. eCollection 2020.

INTRODUCTION: Colorectal cancer (CRC) is one of the most frequently diagnosed tumors in Western countries. CRC is a heterogeneous group of tumors with regards to its molecular pathogenesis and genetic factors. Both genetic variations and anthropometric factors may affect...

Cite
Mrozikiewicz-Rakowska B, Malinowski M, Nehring P, et al. The MDR1/ABCB1 gene rs 1045642 polymorphism in colorectal cancer. Arch Med Sci. 2019;16(1):112-117doi: 10.5114/aoms.2017.70329.
Mrozikiewicz-Rakowska, B., Malinowski, M., Nehring, P., Bartkowiak-Wieczorek, J., Bogacz, A., Żurawińska-Grzelka, E., Krasnodębski, P., Muszyński, J., Grzela, T., Przybyłkowski, A., & Czupryniak, L. (2020). The MDR1/ABCB1 gene rs 1045642 polymorphism in colorectal cancer. Archives of medical science : AMS, 16(1), 112-117. https://doi.org/10.5114/aoms.2017.70329
Mrozikiewicz-Rakowska, Beata, et al. "The MDR1/ABCB1 gene rs 1045642 polymorphism in colorectal cancer." Archives of medical science : AMS vol. 16,1 (2020): 112-117. doi: https://doi.org/10.5114/aoms.2017.70329
Mrozikiewicz-Rakowska B, Malinowski M, Nehring P, Bartkowiak-Wieczorek J, Bogacz A, Żurawińska-Grzelka E, Krasnodębski P, Muszyński J, Grzela T, Przybyłkowski A, Czupryniak L. The MDR1/ABCB1 gene rs 1045642 polymorphism in colorectal cancer. Arch Med Sci. 2019 Sep 26;16(1):112-117. doi: 10.5114/aoms.2017.70329. eCollection 2020. PMID: 32051713; PMCID: PMC6963158.
Copy Download .nbib Format: NLM
Selected RANKL/RANK/OPG system genetic variants in diabetic foot patients.

Journal of diabetes and metabolic disorders

Mrozikiewicz-Rakowska B, Nehring P, Szymański K, Sobczyk-Kopcioł A, Płoski R, Drygas W, Krzymień J, Acharya NA, Czupryniak L, Przybyłkowski A.
PMID: 30918864
J Diabetes Metab Disord. 2018 Nov 09;17(2):287-296. doi: 10.1007/s40200-018-0372-4. eCollection 2018 Dec.

PURPOSE: Diabetic foot is a complication of long-lasting diabetes mellitus affecting up to 15% of patients, both in type 1 and type 2 diabetes. Osteoprotegerin is involved in osteogenesis and calcification. The aim of the study was to assess...

Cite
Mrozikiewicz-Rakowska B, Nehring P, Szymański K, et al. Selected RANKL/RANK/OPG system genetic variants in diabetic foot patients. J Diabetes Metab Disord. 2018;17(2):287-296doi: 10.1007/s40200-018-0372-4.
Mrozikiewicz-Rakowska, B., Nehring, P., Szymański, K., Sobczyk-Kopcioł, A., Płoski, R., Drygas, W., Krzymień, J., Acharya, N. A., Czupryniak, L., & Przybyłkowski, A. (2018). Selected RANKL/RANK/OPG system genetic variants in diabetic foot patients. Journal of diabetes and metabolic disorders, 17(2), 287-296. https://doi.org/10.1007/s40200-018-0372-4
Mrozikiewicz-Rakowska, Beata, et al. "Selected RANKL/RANK/OPG system genetic variants in diabetic foot patients." Journal of diabetes and metabolic disorders vol. 17,2 (2018): 287-296. doi: https://doi.org/10.1007/s40200-018-0372-4
Mrozikiewicz-Rakowska B, Nehring P, Szymański K, Sobczyk-Kopcioł A, Płoski R, Drygas W, Krzymień J, Acharya NA, Czupryniak L, Przybyłkowski A. Selected RANKL/RANK/OPG system genetic variants in diabetic foot patients. J Diabetes Metab Disord. 2018 Nov 09;17(2):287-296. doi: 10.1007/s40200-018-0372-4. eCollection 2018 Dec. PMID: 30918864; PMCID: PMC6405386.
Copy Download .nbib Format: NLM
Diabetic Microvascular Complications.

International journal of endocrinology

Migdalis I, Czupryniak L, Lalic N, Leslie RD, Papanas N, Valensi P.
PMID: 29997650
Int J Endocrinol. 2018 May 28;2018:5683287. doi: 10.1155/2018/5683287. eCollection 2018.

No abstract available.

Cite
Migdalis I, Czupryniak L, Lalic N, et al. Diabetic Microvascular Complications. Int J Endocrinol. 2018;2018:5683287doi: 10.1155/2018/5683287.
Migdalis, I., Czupryniak, L., Lalic, N., Leslie, R. D., Papanas, N., & Valensi, P. (2018). Diabetic Microvascular Complications. International journal of endocrinology, 20185683287. https://doi.org/10.1155/2018/5683287
Migdalis, I, et al. "Diabetic Microvascular Complications." International journal of endocrinology vol. 2018 (2018): 5683287. doi: https://doi.org/10.1155/2018/5683287
Migdalis I, Czupryniak L, Lalic N, Leslie RD, Papanas N, Valensi P. Diabetic Microvascular Complications. Int J Endocrinol. 2018 May 28;2018:5683287. doi: 10.1155/2018/5683287. eCollection 2018. PMID: 29997650; PMCID: PMC5994569.
Copy Download .nbib Format: NLM
Nocturnal Oxygen Saturation Parameters as Independent Risk Factors for Type 2 Diabetes Mellitus among Obstructive Sleep Apnea Patients.

Journal of clinical medicine

Gabryelska A, Chrzanowski J, Sochal M, Kaczmarski P, Turkiewicz S, Ditmer M, Karuga FF, Czupryniak L, Białasiewicz P.
PMID: 34501217
J Clin Med. 2021 Aug 24;10(17). doi: 10.3390/jcm10173770.

Obstructive sleep apnea (OSA) is a recognized independent risk factor for metabolic disorders, type 2 diabetes mellites (DM2) in particular. Therefore, the study aimed to assess the influence of nocturnal oxygen saturation parameters on the onset of DM2 among...

Cite
Gabryelska A, Chrzanowski J, Sochal M, et al. Nocturnal Oxygen Saturation Parameters as Independent Risk Factors for Type 2 Diabetes Mellitus among Obstructive Sleep Apnea Patients. J Clin Med. 2021;10(17)doi: 10.3390/jcm10173770.
Gabryelska, A., Chrzanowski, J., Sochal, M., Kaczmarski, P., Turkiewicz, S., Ditmer, M., Karuga, F. F., Czupryniak, L., & Białasiewicz, P. (2021). Nocturnal Oxygen Saturation Parameters as Independent Risk Factors for Type 2 Diabetes Mellitus among Obstructive Sleep Apnea Patients. Journal of clinical medicine, 10(17), . https://doi.org/10.3390/jcm10173770
Gabryelska, Agata, et al. "Nocturnal Oxygen Saturation Parameters as Independent Risk Factors for Type 2 Diabetes Mellitus among Obstructive Sleep Apnea Patients." Journal of clinical medicine vol. 10,17 (2021). doi: https://doi.org/10.3390/jcm10173770
Gabryelska A, Chrzanowski J, Sochal M, Kaczmarski P, Turkiewicz S, Ditmer M, Karuga FF, Czupryniak L, Białasiewicz P. Nocturnal Oxygen Saturation Parameters as Independent Risk Factors for Type 2 Diabetes Mellitus among Obstructive Sleep Apnea Patients. J Clin Med. 2021 Aug 24;10(17). doi: 10.3390/jcm10173770. PMID: 34501217; PMCID: PMC8432118.
Copy Download .nbib Format: NLM
Sodium-glucose co-transporter-2 inhibitors for type 1 diabetes: Not any more?.

Diabetes, obesity & metabolism

Czupryniak L, Danne T, Szymańska-Garbacz E, Zozulińska-Ziółkiewicz D, Gumprecht J, Klupa T.
PMID: 34931428
Diabetes Obes Metab. 2021 Dec 21; doi: 10.1111/dom.14631. Epub 2021 Dec 21.

No abstract available.

Cite
Czupryniak L, Danne T, Szymańska-Garbacz E, et al. Sodium-glucose co-transporter-2 inhibitors for type 1 diabetes: Not any more?. Diabetes Obes Metab. 2021;doi: 10.1111/dom.14631.
Czupryniak, L., Danne, T., Szymańska-Garbacz, E., Zozulińska-Ziółkiewicz, D., Gumprecht, J., & Klupa, T. (2021). Sodium-glucose co-transporter-2 inhibitors for type 1 diabetes: Not any more?. Diabetes, obesity & metabolism, . https://doi.org/10.1111/dom.14631
Czupryniak, Leszek, et al. "Sodium-glucose co-transporter-2 inhibitors for type 1 diabetes: Not any more?." Diabetes, obesity & metabolism vol. (2021). doi: https://doi.org/10.1111/dom.14631
Czupryniak L, Danne T, Szymańska-Garbacz E, Zozulińska-Ziółkiewicz D, Gumprecht J, Klupa T. Sodium-glucose co-transporter-2 inhibitors for type 1 diabetes: Not any more?. Diabetes Obes Metab. 2021 Dec 21; doi: 10.1111/dom.14631. Epub 2021 Dec 21. PMID: 34931428.
Copy Download .nbib Format: NLM
Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Haluzik M, Kretowski A, Strojek K, Czupryniak L, Janez A, Kempler P, Andel M, Tankova T, Boyanov M, Smircic Duvnjak L, Madacsy L, Tarnowska I, Zychma M, Lalic N.
PMID: 29524189
Diabetes Ther. 2018 Apr;9(2):727-741. doi: 10.1007/s13300-018-0388-2. Epub 2018 Mar 09.

INTRODUCTION: The aim of this study was to determine the level of awareness of hypoglycemia, the level of fear for hypoglycemia, and the response to hypoglycemic events among insulin-treated diabetes patients from Central and Eastern Europe (CEE). The impact...

Cite
Haluzik M, Kretowski A, Strojek K, et al. Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries. Diabetes Ther. 2018;9(2):727-741doi: 10.1007/s13300-018-0388-2.
Haluzik, M., Kretowski, A., Strojek, K., Czupryniak, L., Janez, A., Kempler, P., Andel, M., Tankova, T., Boyanov, M., Smircic Duvnjak, L., Madacsy, L., Tarnowska, I., Zychma, M., & Lalic, N. (2018). Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries. Diabetes therapy : research, treatment and education of diabetes and related disorders, 9(2), 727-741. https://doi.org/10.1007/s13300-018-0388-2
Haluzik, Martin, et al. "Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 9,2 (2018): 727-741. doi: https://doi.org/10.1007/s13300-018-0388-2
Haluzik M, Kretowski A, Strojek K, Czupryniak L, Janez A, Kempler P, Andel M, Tankova T, Boyanov M, Smircic Duvnjak L, Madacsy L, Tarnowska I, Zychma M, Lalic N. Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries. Diabetes Ther. 2018 Apr;9(2):727-741. doi: 10.1007/s13300-018-0388-2. Epub 2018 Mar 09. PMID: 29524189; PMCID: PMC6104285.
Copy Download .nbib Format: NLM
Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Kalra S, Czupryniak L, Kilov G, Lamptey R, Kumar A, Unnikrishnan AG, Boudiba A, Abid M, Akanov ZA, Latheef A, Araz M, Audehm R, Bahendeka S, Balde N, Chaudhary S, Deerochanawong C, Fasanmade O, Iraqi H, Latt TS, Mbanya JC, Rodriguez-Saldana J, Hyun KS, Latif ZA, Lushchyk M, Megallaa M, Naseri MW, Bay NQ, Ramaiya K, Randeree H, Raza SA, Shaikh K, Shrestha D, Sobngwi E, Somasundaram N, Sukor N, Tan R.
PMID: 30390228
Diabetes Ther. 2018 Dec;9(6):2185-2199. doi: 10.1007/s13300-018-0521-2. Epub 2018 Nov 03.

Premixed insulins are an important tool for glycemic control in persons with diabetes. Equally important in diabetes care is the selection of the most appropriate insulin regimen for a particular individual at a specific time. Currently, the choice of...

Cite
Kalra S, Czupryniak L, Kilov G, et al. Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care. Diabetes Ther. 2018;9(6):2185-2199doi: 10.1007/s13300-018-0521-2.
Kalra, S., Czupryniak, L., Kilov, G., Lamptey, R., Kumar, A., Unnikrishnan, A. G., Boudiba, A., Abid, M., Akanov, Z. A., Latheef, A., Araz, M., Audehm, R., Bahendeka, S., Balde, N., Chaudhary, S., Deerochanawong, C., Fasanmade, O., Iraqi, H., Latt, T. S., Mbanya, J. C., Rodriguez-Saldana, J., Hyun, K. S., Latif, Z. A., Lushchyk, M., Megallaa, M., Naseri, M. W., Bay, N. Q., Ramaiya, K., Randeree, H., Raza, S. A., Shaikh, K., Shrestha, D., Sobngwi, E., Somasundaram, N., Sukor, N., & Tan, R. (2018). Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care. Diabetes therapy : research, treatment and education of diabetes and related disorders, 9(6), 2185-2199. https://doi.org/10.1007/s13300-018-0521-2
Kalra, Sanjay, et al. "Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 9,6 (2018): 2185-2199. doi: https://doi.org/10.1007/s13300-018-0521-2
Kalra S, Czupryniak L, Kilov G, Lamptey R, Kumar A, Unnikrishnan AG, Boudiba A, Abid M, Akanov ZA, Latheef A, Araz M, Audehm R, Bahendeka S, Balde N, Chaudhary S, Deerochanawong C, Fasanmade O, Iraqi H, Latt TS, Mbanya JC, Rodriguez-Saldana J, Hyun KS, Latif ZA, Lushchyk M, Megallaa M, Naseri MW, Bay NQ, Ramaiya K, Randeree H, Raza SA, Shaikh K, Shrestha D, Sobngwi E, Somasundaram N, Sukor N, Tan R. Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care. Diabetes Ther. 2018 Dec;9(6):2185-2199. doi: 10.1007/s13300-018-0521-2. Epub 2018 Nov 03. PMID: 30390228; PMCID: PMC6250631.
Copy Download .nbib Format: NLM
Radionuclide imaging and therapy in a patient with coexistent diabetic foot syndrome and psoriatic arthritis.

Nuclear medicine review. Central & Eastern Europe

Chojnowski MM, Mrozikiewicz-Rakowska B, Kobylecka M, Czupryniak L, Królicki L.
PMID: 30900238
Nucl Med Rev Cent East Eur. 2017;20(2):101-102. doi: 10.5603/NMR.2017.0016.

We report a case of 67-year-old man suffering from psoriatic arthritis, type 2 diabetes and diabetic foot syndrome. The patient presented symptoms of inflammation of the right ankle joint. Scintigraphic imaging with radiolabeled white blood cells was performed to...

Cite
Chojnowski MM, Mrozikiewicz-Rakowska B, Kobylecka M, et al. Radionuclide imaging and therapy in a patient with coexistent diabetic foot syndrome and psoriatic arthritis. Nucl Med Rev Cent East Eur. 2017;20(2):101-102doi: 10.5603/NMR.2017.0016.
Chojnowski, M. M., Mrozikiewicz-Rakowska, B., Kobylecka, M., Czupryniak, L., & Królicki, L. (2017). Radionuclide imaging and therapy in a patient with coexistent diabetic foot syndrome and psoriatic arthritis. Nuclear medicine review. Central & Eastern Europe, 20(2), 101-102. https://doi.org/10.5603/NMR.2017.0016
Chojnowski, Marek Marcin, et al. "Radionuclide imaging and therapy in a patient with coexistent diabetic foot syndrome and psoriatic arthritis." Nuclear medicine review. Central & Eastern Europe vol. 20,2 (2017): 101-102. doi: https://doi.org/10.5603/NMR.2017.0016
Chojnowski MM, Mrozikiewicz-Rakowska B, Kobylecka M, Czupryniak L, Królicki L. Radionuclide imaging and therapy in a patient with coexistent diabetic foot syndrome and psoriatic arthritis. Nucl Med Rev Cent East Eur. 2017;20(2):101-102. doi: 10.5603/NMR.2017.0016. PMID: 30900238.
Copy Download .nbib Format: NLM
Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Janež A, Guja C, Mitrakou A, Lalic N, Tankova T, Czupryniak L, Tabák AG, Prazny M, Martinka E, Smircic-Duvnjak L.
PMID: 31902063
Diabetes Ther. 2020 Feb;11(2):387-409. doi: 10.1007/s13300-019-00743-7. Epub 2020 Jan 04.

Here, we review insulin management options and strategies in nonpregnant adult patients with type 1 diabetes mellitus (T1DM). Most patients with T1DM should follow a regimen of multiple daily injections of basal/bolus insulin, but those not meeting individual glycemic...

Cite
Janež A, Guja C, Mitrakou A, et al. Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review. Diabetes Ther. 2020;11(2):387-409doi: 10.1007/s13300-019-00743-7.
Janež, A., Guja, C., Mitrakou, A., Lalic, N., Tankova, T., Czupryniak, L., Tabák, A. G., Prazny, M., Martinka, E., & Smircic-Duvnjak, L. (2020). Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review. Diabetes therapy : research, treatment and education of diabetes and related disorders, 11(2), 387-409. https://doi.org/10.1007/s13300-019-00743-7
Janež, Andrej, et al. "Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 11,2 (2020): 387-409. doi: https://doi.org/10.1007/s13300-019-00743-7
Janež A, Guja C, Mitrakou A, Lalic N, Tankova T, Czupryniak L, Tabák AG, Prazny M, Martinka E, Smircic-Duvnjak L. Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review. Diabetes Ther. 2020 Feb;11(2):387-409. doi: 10.1007/s13300-019-00743-7. Epub 2020 Jan 04. PMID: 31902063; PMCID: PMC6995794.
Copy Download .nbib Format: NLM
Utility of different serum fibrosis markers in diagnosing patients with chronic pancreatitis and pancreatic adenocarcinoma.

World journal of gastrointestinal oncology

Kozak A, Talar-Wojnarowska R, Kaczka A, Borkowska A, Czupryniak L, Małecka-Panas E, Gąsiorowska A.
PMID: 27574557
World J Gastrointest Oncol. 2016 Aug 15;8(8):635-41. doi: 10.4251/wjgo.v8.i8.635.

AIM: To estimate the levels of serum cytokines in chronic pancreatitis (CP) and pancreatic ductal adenocarcinoma (PDAC) patients in order to evaluate their usefulness as possible biomarkers.METHODS: The study included 167 Caucasian patients: 74 with PDAC (28 men and...

Cite
Kozak A, Talar-Wojnarowska R, Kaczka A, et al. Utility of different serum fibrosis markers in diagnosing patients with chronic pancreatitis and pancreatic adenocarcinoma. World J Gastrointest Oncol. 2016;8(8):635-41doi: 10.4251/wjgo.v8.i8.635.
Kozak, A., Talar-Wojnarowska, R., Kaczka, A., Borkowska, A., Czupryniak, L., Małecka-Panas, E., & Gąsiorowska, A. (2016). Utility of different serum fibrosis markers in diagnosing patients with chronic pancreatitis and pancreatic adenocarcinoma. World journal of gastrointestinal oncology, 8(8), 635-41. https://doi.org/10.4251/wjgo.v8.i8.635
Kozak, Anna, et al. "Utility of different serum fibrosis markers in diagnosing patients with chronic pancreatitis and pancreatic adenocarcinoma." World journal of gastrointestinal oncology vol. 8,8 (2016): 635-41. doi: https://doi.org/10.4251/wjgo.v8.i8.635
Kozak A, Talar-Wojnarowska R, Kaczka A, Borkowska A, Czupryniak L, Małecka-Panas E, Gąsiorowska A. Utility of different serum fibrosis markers in diagnosing patients with chronic pancreatitis and pancreatic adenocarcinoma. World J Gastrointest Oncol. 2016 Aug 15;8(8):635-41. doi: 10.4251/wjgo.v8.i8.635. PMID: 27574557; PMCID: PMC4980655.
Copy Download .nbib Format: NLM
Differences in risk factors of malignancy between men and women with type 2 diabetes: A retrospective case-control study.

Oncotarget

Dąbrowski M, Szymańska-Garbacz E, Miszczyszyn Z, Dereziński T, Czupryniak L.
PMID: 28978007
Oncotarget. 2017 May 09;8(40):66940-66950. doi: 10.18632/oncotarget.17716. eCollection 2017 Sep 15.

BACKGROUND: The aim of this multicenter, retrospective, case-control study was to identify differences in risk factors of malignancy between men and women with type 2 diabetes.RESULTS: Among women the most prevalent malignancies were: breast and uterine cancers (35.6% and...

Cite
Dąbrowski M, Szymańska-Garbacz E, Miszczyszyn Z, et al. Differences in risk factors of malignancy between men and women with type 2 diabetes: A retrospective case-control study. Oncotarget. 2017;8(40):66940-66950doi: 10.18632/oncotarget.17716.
Dąbrowski, M., Szymańska-Garbacz, E., Miszczyszyn, Z., Dereziński, T., & Czupryniak, L. (2017). Differences in risk factors of malignancy between men and women with type 2 diabetes: A retrospective case-control study. Oncotarget, 8(40), 66940-66950. https://doi.org/10.18632/oncotarget.17716
Dąbrowski, Mariusz, et al. "Differences in risk factors of malignancy between men and women with type 2 diabetes: A retrospective case-control study." Oncotarget vol. 8,40 (2017): 66940-66950. doi: https://doi.org/10.18632/oncotarget.17716
Dąbrowski M, Szymańska-Garbacz E, Miszczyszyn Z, Dereziński T, Czupryniak L. Differences in risk factors of malignancy between men and women with type 2 diabetes: A retrospective case-control study. Oncotarget. 2017 May 09;8(40):66940-66950. doi: 10.18632/oncotarget.17716. eCollection 2017 Sep 15. PMID: 28978007; PMCID: PMC5620147.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 16 entries